NCT02429791 · Interventional trial
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
Overall registry status Completed
Phase 3
Conditions HIV Infections
Delaware Valley sites
- GSK Investigational Site · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory